🧾 West Virginia’s $34M Freeze, Florida’s Money Trail, and the Hemp Clock

Built by a former cannabis regulator, Policy, Decoded helps operators read the policy terrain before it shifts beneath their feet.

Today’s edition starts in West Virginia, where the state has collected roughly $34 million in medical cannabis revenue and disbursed none of it, turning a statutory promise into a confidence problem for the program and the industry. We also track Florida’s Medicaid settlement money colliding with marijuana politics, the growing gap between rescheduling headlines and real-world banking access, and the narrowing window for hemp as states and retailers brace for a federal clock that keeps ticking.

Today’s edition is supported by 1440 Media. This briefing is also supported by our day job at THC Group, where we provide strategic counsel for policy, regulatory, and political headaches that do not come with clean rulebooks. Want to sponsor a future edition? Reach out!

🏦 Money collected, trust withheld
🌾 Hemp on a deadline
🧾 Governance under pressure

Follow the money.

📌 What Happened: West Virginia has collected roughly $34 million from its medical cannabis program since dispensaries opened in late 2021 and has disbursed none of it. State law created the Medical Cannabis Program Fund and set mandatory percentage allocations for program administration and research, substance use treatment, law enforcement grants, and law enforcement training. The Treasurer’s Office has said the funds will remain untouched until federal law changes, and the money continues to sit outside the state’s normal disbursement flow. That position traces back to banking concerns raised before the first dispensary opened, when the state was still solving how to accept deposits at all. Several lawmakers involved in writing both the cannabis statute and the banking fix say they did not understand the law to freeze funds after collection.

💡 Why It Matters: Cannabis revenue gets sold as a two-for-one. Patients get access, the state gets a new program paid for by its own users, and the leftover dollars fund a list of public goods that poll well. Oversight and enforcement belong on that list because they keep the system credible and safe. The broader earmarks can still make sense, and they still require one thing first: the money has to move. West Virginia collected the dollars, told everyone where they would go, and then left them sitting. That is how you turn a policy choice into cynicism and a functioning program into a punchline.

💰 Florida Medicaid Settlement Money Trails Into Marijuana Politics

Reporting shows that weeks after the DeSantis administration directed $10 million from a Medicaid settlement into the Hope Florida Foundation, the foundation sent $5 million grants to two nonprofits that later routed millions into political committees opposing Florida’s adult use marijuana amendment. Campaign finance records show money moving through committees tied to the governor’s inner circle, raising questions about whether public settlement dollars were converted into political spending. Florida House Republicans have opened records demands and are probing whether the funding path violated state law or nonprofit restrictions. The administration and affiliated committees deny wrongdoing, and precise tracing stays difficult as money moves between entities. The consequence is a credibility and compliance problem that blends Medicaid oversight, legislative investigation, and ballot politics into one escalating governance story. (Miami Herald)

🏦 Big Banks Stay On The Sidelines Despite Rescheduling Order

Major U.S. banks continue to avoid cannabis accounts after President Trump’s December 18th executive order pushing marijuana rescheduling because the legal risk profile does not change until the government completes the process. Large institutions are still treating cannabis as a charter, enforcement, and reputational exposure issue, with insured status and supervision doing the governing. Most operators remain stuck with smaller banks, credit unions, and higher-cost workarounds. Rescheduling can help the tax posture once it is final, and it can steady investor sentiment, while it does not deliver immediate banking certainty. The consequence is sustained pressure on Capitol Hill for a banking fix and continued operational friction across the market. (MJBizDaily)

📈 Cannabis Finance Starts Acting Like A Real Industry Again

A new analysis traces how the rescheduling order has shifted sentiment in boardrooms and capital markets even before the paperwork is finished. The financial hinge is Schedule III, which would ease the federal tax penalty that has distorted margins and kept balance sheets fragile. Investors are already modeling consolidation, credit reentry, and more conventional deal structures, while lenders keep risk posture tight until the change is formal and defensible. If the process drags or gets litigated, capital plans can freeze as quickly as they thawed. The consequence is a market that starts planning for normalized finance while compliance risk still sets the speed limit. (Quartz)

🏪 Hemp THC Ban Puts Convenience Stores On A Clock

NACS warns that a federal change scheduled for November 12th could wipe out intoxicating hemp products and beverages unless Congress intervenes. Retailers see real category growth in states that have imposed adult guardrails, and they also see the liability when rules vary and youth protection becomes the headline. A hard federal line would force rapid product pulls and leave retailers explaining whiplash to customers and regulators. The next year becomes an advocacy sprint aimed at keeping compliant, age-gated models in the lawful channel while shutting down synthetics and evasive products. The consequence is procurement and shelf planning built around political timing rather than consumer demand. (NACS Convenience.org)

🌾 Indiana Hemp Bill Clears Committee And Triggers Industry Pushback

An Indiana Senate committee advanced a bill to align state hemp law with looming federal changes, and the hemp industry is warning that a blunt alignment could sweep up lawful products along with the bad actors. Supporters are treating this as a calendar problem, with November hanging over regulators and retailers who do not want a last-minute scramble. The fight is over definitions and channel rules as lawmakers try to corral intoxicating products that have drawn youth protection scrutiny. Industry voices are pushing for guardrails that preserve legitimate CBD supply chains and disciplined, age-gated low dose beverage models while tightening enforcement against synthetics and evasive products. The consequence is an earlier state-level shakeout, with compliance investment becoming the price of admission and ambiguity becoming a liability. (Ganjapreneur, WOWO)

🌱 Hemp Farmers Push Congress To Protect Planting Season Certainty

Rep. Jim Baird’s Hemp Planting Predictability Act would extend the current hemp definition timeline by two years, giving growers a stable rule set for seed orders, acreage, and contracts. The politically meaningful shift is who is driving it, with farmers putting their name on the problem and framing it as basic agricultural planning. That constituency expands the coalition beyond brands and trade groups and gives members a district-grounded reason to engage. The extension also keeps pressure on Congress to write a durable framework that separates compliant CBD supply chains and disciplined low dose adult beverage models from synthetics and evasive products. The consequence is a narrow window to legislate with credibility before planting decisions turn into a vote of no confidence in federal oversight. (Cannabis Equipment News)

🧩 CBD Gets Lost When Congress Treats Hemp Like One Problem

An op ed argues that pushing the federal hemp deadline out a couple years buys time while leaving farmers and patients who rely on lawful CBD in continued uncertainty. The case turns on differentiation, with nonintoxicating cannabinoid commerce needing a distinct lane from intoxicating products that have drawn enforcement heat and youth protection scrutiny. A blunt federal definition change can knock compliant CBD out of mainstream retail while bad actors pivot faster and stay harder to police. Contracts, lending, and product development are already being priced around the November 2026 cliff. The consequence is pressure for a national compliance framework that protects access, requires testing and labeling, and gives enforcers a clean basis to shut down evasion. (Marijuana Moment)

🥂 THC Drinks Are Showing Up In The Event Bar Plan

Event planners and beverage teams are starting to treat THC seltzers and spirits alternatives as a real hospitality option, especially for Dry January crowds who still want a social ritual. Brands and organizers are borrowing the nonalcoholic playbook, with dosage clarity and predictability as the selling point. The category is also staring at a policy cliff, with federal and state moves that could sharply narrow what stays legal on mainstream shelves. That uncertainty already shapes where these products can be served, how they are staffed, and whether venues will take the compliance risk. The consequence for hospitality is a menu decision governed as much by enforcement posture as by consumer demand. (BizBash)

📊 Federal Drug Scheduling Drifts From Scientific Harm Rankings, New Review Finds

A new scientific review concludes that legal drug classifications in the United States and other countries do not track expert assessments of relative harm, leaving cannabis over-classified compared with substances experts rate as more dangerous. The authors frame the gap as a governance failure rooted in Controlled Substances Act era categories that stayed rigid while evidence and patterns of use evolved. In Washington, the study gives rescheduling advocates fresh academic support while the administrative process remains the only near-term mechanism to move schedules. Courts and lawmakers may cite the review as part of broader arguments about rationality and proportionality. The consequence is narrative leverage for reformers without any immediate legal change for businesses or consumers. (Marijuana Moment)

🧬 Epigenetics May Explain Why Some Cultivars Hit Harder And Smell Better

A new study links differences in chromatin accessibility to the way cannabis turns key biosynthesis pathways on and off, shaping cannabinoid output and the terpene and flavonoid profile that drives aroma and flavor. The work points to measurable biological markers that can separate two plants with similar genetics into very different commercial outcomes. For breeders and cultivators, that opens the door to more repeatable targets for potency and sensory traits. It also sharpens the labeling and consistency conversation, since the industry sells precise experiences while agriculture delivers variability. The consequence is a clearer path to stable cultivars that test and taste the way buyers expect, with fewer surprises batch to batch. (Cannabis Industry Journal)

🗳️ Maine Voter Claims Marijuana Petition Pitch Crossed A Line

A Maine man says signature gatherers misled him about whether a petition concerned recreational or medical marijuana, adding fuel to a recurring fight over ballot integrity. The allegation lands in a system that relies heavily on paid circulators and simplified scripts to move quickly under deadline pressure. State officials say disputes like this are hard to police after the fact unless there is a clear pattern or documented misrepresentation. Opponents will use even isolated claims to argue for tighter initiative rules and more aggressive oversight. The consequence is heightened scrutiny on circulator training and campaign compliance, with process disputes taking oxygen from the substance of the measure. (WGME)